‘Rules4Schools’ campaign news from Young Epilepsy and Veriton Pharma
Category: Industry News
Advantages and disadvantages of taking Z drugs to treat sleep disturbance in people with dementia
News from The Alzheimer’s Association International Conference (AAIC)
Akcea and Ionis Announce European Commission Approval of Tegsedi™ ▼ (inotersen)
News from Akcea Therapeutics, Inc., and Ionis Pharmaceuticals, Inc.
Celebrating 16 years of the Parkinson’s MasterClass
News from the Neurology Academy
Assessment of mental health issues in Parkinson’s disease
Runner up project from the 2017 Parkinson’s Academy
INSIGHTEC’s Focused Ultrasound Earns Positive NICE Guidance for Treatment of Essential Tremor
News from Insightec
NICE recommends OCREVUS®▼ (ocrelizumab) for people with relapsing-remitting multiple sclerosis
Significant milestone for people with multiple sclerosis as people with relapsing-remitting form gain access to new first-in-class treatment with twice-yearly dosing
NICE issues guidance on disease modifying therapies for multiple sclerosis
News from NICE
Epistatus®10 mg (in 1 ml) oromucosal solution Midazolam available on NHS prescription is approved for use by both the Scottish Medicines Consortium (SMC) and the All Wales Medicines Strategy Group (AWMSG)
News from Veriton Pharma on Epistatus
